ZAINA PHARMA
Largo
About ZAINA PHARMA
Zaina Pharma, Inc. manufactures and commercializes pharmaceutical, medical devices, and cosmetic products primarily in the fields of dermatology and aesthetic medicine. It offers topical brightening system, a skin brightening peptide to reduce hyper pigmentation without any toxicity; VISAGEL Cross-linked hyaluronic acid dermal fillers; and ZainaSol, a physical sun screen that protects from harmful radiation using titanium and zinc as physical screens. The company distributes its products through a network of affiliated companies. It serves customers in the United States, Canada, Argentina, Brazil, Columbia, Mexico, Peru, the United Kingdom, France, Germany, Greece, Portugal, Poland, Monaco, Turkey, Jordan, Egypt, China, Indonesia, Japan, Singapore, Malaysia, Vietnam, Taiwan, Hon-Kong, South-Korea, and Uzbekistan. The company was founded in 2009 and is based in Largo, Florida.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $250.0K
- Funding stage: Seed
- Last round: Seed (Jul 2010)
- Website: zaina.lt
Industries & Categories
Health Care, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/zaina-pharma-3335234 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.